-Down to Earth US continues to question India’s patent regime in its latest report. The country was kept in the category where unfavorable conditions exist for ‘innovation’ In April, US president Barack Obama wrote a piece in the Time magazine, praising Prime Minister Narendra Modi. For a few people it might have been a happy moment, but for others it was scary as they tried to read between the lines as to...

-CurrentNews.in ‘Make in India' an empty slogan; Govt promotes ‘Sell in India'  The government of the USA is pushing India to revise its existing robust Intellectual Property (IP) framework that effectively protects the national and public interest by balancing the rights of IP owners with their obligation to society. Submitting to the US agenda will adversely impact innovation, production and prices, especially of medicines and medical care. Multinational pharmaceutical companies will reap...

-Economic and Political Weekly While the Protection of Plant Varieties and Farmers' Rights Act 2001 is a progressive piece of legislation that recognises farmers' rights to seed, it demands payment of an annual maintenance fee by the farmers to protect the varieties which they have been cultivating and conserving for years, only because these varieties have been brought under legal protection through national legislation. Parameswaran Prajeesh (prajeesh@mssrf.res.in) is a researcher with the...

-Business Standard Intellectual property policy should focus on implementation A preliminary draft of a new Intellectual Property Rights policy for India has been the occasion for much discussion. Commerce Minister Nirmala Sitharaman even felt it necessary to assert on Twitter that the proposed revamp is not meant to appease the United States, given that this remains a major outstanding irritant in relations between the two countries. The government has argued that the...

-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...